EZH2 and small cell lung carcinoma: A specific EZH2 inhibitor induced TGFBR2 expression (Figure 4b); therefore, EZH2 inhibitors may also effectively eradicate SCLC cells by restoring TβRII expression, and thus, enabling TGF-β-mediated apoptosis.